Skip to main content

Closed

TGTX: TG Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Operating margin21.3%

ROIC11.1%

Financially safe

Strong

Debt / equity1.29×

Interest coverage5.4×

Current ratio5.81×

Valuation

Unrated

P/E ratio16.4×

TG Therapeutics, Inc.

TGTXNASDAQ Capital Market·USD·Closed

TG Therapeutics, Inc.

TGTXNASDAQ·USD·Closed

$52.03

−2.80%

$52.03

−$1.50 (2.80%)

52W Range

79thpctl

Volume

1.02×avg

Mkt Cap

7.96BUSD

P/E

16.4TTM

Div Yield

–ann

52W Range

79thpctl

Volume

1.02×avg

Market Cap

7.96BUSD

P/E Ratio

16.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings